ESMO Conference Platform

ESMO Sarcoma and Rare Cancers 2023

Final Programme PDF Advanced Search

08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00

Hall A

09:00(1h 20m)Evolving classification of sarcomas
13:15(1h)Is HTA (Health Technology Assessment) applicable to rare cancers?
08:55(05m)Opening session
16:20(1h 20m)The evolution of local/ablative therapeutic approaches in sarcomas
10:50(1h 20m)Ultra rare sarcomas
14:30(1h 20m)What to do after whoops surgery of soft tissue sarcoma (STS)

Hall B1

09:00(1h 20m)Improving the continuum of care in rare gynaecological and genitourinary oncology
14:30(1h 20m)Management of GEP NENs
16:20(1h 20m)Managing patients with ultra rare thoracic and head neck tumours of ultra rare histologies
10:50(1h 20m)Proffered paper session – Rare Cancers

Hall B3

10:50(1h 20m)Non-skin melanoma, adnexal tumours and Merkel cell carcinoma
16:20(1h 20m)Patient advocacy on rare cancers
09:00(1h 20m)Rare cancers and tumour agnostic oncology
14:30(1h 20m)Sarcoma Patient Advocacy Global Network (SPAGN) session: Research for patient benefit

Foyer (First floor)

12:15(45m)YO Mentorships: Research in rare cancers

Foyer (Ground floor)

10:20(30m)Coffee break
15:50(30m)Coffee break
12:10(1h)Lunch